A Phase Ib/II Study, Evaluating the Safety and Efficacy of Idasanutlin in Combination with Cytarabine and Daunorubicin in Patients Newly Diagnosed with Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission.

  • Wei, Andrew (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

StatusActive
Effective start/end date17/07/1931/12/26

Keywords

  • Malignant Haematology
  • Acute Myeloid Leukaemia (AML)
  • Clinical trial
  • Malignant Haematology
  • Acute Myeloid Leukaemia (AML)
  • Clinical trial
  • Malignant Haematology
  • Acute Myeloid Leukaemia (AML)
  • Clinical trial